Linking human beta retrovirus infection with primary biliary cirrhosis

Gastroenterologie Clinique et Biologique

Volumn 34, Issue 6-7, 2010, Pages 359-366

  Mason, A L ^a   Zhang, G ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; AUTOANTIGEN; CHENODEOXYCHOLIC ACID DERIVATIVE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; MITOCHONDRIAL PROTEIN; OBETICHOLIC ACID; PLACEBO; PRODRUG; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VIRUS PROTEIN; XENOBIOTIC AGENT; ZIDOVUDINE;

AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; AUTOIMMUNE DISEASE; CLINICAL TRIAL; DISEASE ASSOCIATION; GENE MUTATION; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOCHEMISTRY; MOLECULAR CLONING; NONHUMAN; NOVOSPHINGOBIUM; PATHOGENICITY; PHENOTYPE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; PROTEIN EXPRESSION; RETROVIRUS; RETROVIRUS INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SHORT SURVEY;

ANIMALS; ANTI-RETROVIRAL AGENTS; DISEASE MODELS, ANIMAL; DNA, VIRAL; HUMANS; LIVER CIRRHOSIS, BILIARY; MICE; PREVALENCE; RETROVIRIDAE; RETROVIRIDAE INFECTIONS;

EID: 77955319590     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gcb.2010.04.014     Document Type: Short Survey

References (60)

1. Joplin R., Gershwin M.E. Ductular expression of autoantigens in primary biliary cirrhosis. Semin Liver Dis 1997, 17:97-103.
2. Mason A., Nair S. Primary biliary cirrhosis: new thoughts on pathophysiology and treatment. Curr Gastroenterol Rep 2002, 4:45-51.
3. Selmi C., Cocchi C.A., Zuin M., Gershwin M.E. The chemical pathway to primary biliary cirrhosis. Clin Rev Allergy Immunol 2008.
4. Selmi C., Balkwill D.L., Invernizzi P., Ansari A.A., Coppel R.L., Podda M., et al. Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 2003, 38:1250-1257.
5. Wasilenko S., Mason G., Mason A. Primary biliary cirrhosis, bacteria and molecular mimicry: what's the molecule and where's the mimic?. Liver Int 2009, 29:779-782.
6. Sadamoto T., Joplin R., Keogh A., Mason A., Carman W., Neuberger J. Expression of pyruvate-dehydrogenase complex PDC-E2 on biliary epithelial cells induced by lymph nodes from primary biliary cirrhosis. Lancet 1998, 352:1595-1596.
7. Xu L., Shen Z., Guo L., Fodera B., Keogh A., Joplin R., et al. Does a beta retrovirus infection trigger primary biliary cirrhosis?. Proc Natl Acad Sci of the U S A 2003, 100:8454-8459.
8. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpes virus-like DNA sequences in AID's associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
9. Xu L., Guo L., Shen Z., Loss G., Gish R., Wasilenko S., et al. Duplication of MER115 on chromosome 4 in patients with primary biliary cirrhosis. Liver Int 2009, 29:375-383.
10. Garry R.F., Fermin C.D., Hart D.J., Alexander S.S., Donehower L.A., Luo-Zhang H. Detection of a human intracisternal A-type retroviral particle antigenically related to HIV. Science 1990, 250:1127-1129.
11. Mason A.L., Xu L., Guo L., Munoz S., Jaspan J.B., Bryer-Ash M., et al. Detection of retroviral antibodies in primary biliary cirrhosis and other idiopathic biliary disorders. Lancet 1998, 351:1620-1624.
12. Xu L., Sakalian M., Shen Z., Loss G., Neuberger J., Mason A. Cloning the human beta retrovirus proviral genome from patients with primary biliary cirrhosis. Hepatology 2004, 39:151-156.
13. Liu B., Wang Y., Melana S.M., Pelisson I., Najfeld V., Holland J.F., et al. Identification of a proviral structure in human breast cancer. Cancer Res 2001, 61:1754-1759.
14. Hunter E, Casey J, Hahn B, Hayami M, Korber B, Kurth R, et al. Seventh report of the International Committee on taxonomy of viruses. Academic Press, London, San Diego (1999) Virus Taxonomy: Seventh Report of the International Committee on Taxonomy of Viruses (Academic, London).
15. Bittner J.J. Some possible effects of nursing on the mammary gland tumor incidence in mice. Science 1936, 84:162.
16. Bentvelzen P. The biology of the mouse mammary tumor virus. Int Rev Exp Pathol 1972, 11:259-297.
17. Moore D.H., Charney J., Kramarsky B., Lasfargues E.Y., Sarkar N.H., Brennan M.J., et al. Search for a human breast cancer virus. Nature 1971, 229:611-615.
18. Etkind P., Du J., Khan A., Pillitteri J., Wiernik P.H. Mouse mammary tumor virus-like ENV gene sequences in human breast tumors and in a lymphoma of a breast cancer patient. Clin Cancer Res 2000, 6:1273-1278.
19. Ford C.E., Tran D., Deng Y., Ta V.T., Rawlinson W.D., Lawson J.S. Mouse mammary tumor virus-like gene sequences in breast tumors of Australian and Vietnamese women. Clin Cancer Res 2003, 9:1118-1120.
20. Holland J.F., Pogo B.G. Mouse mammary tumor virus-like viral infection and human breast cancer. Clin Cancer Res 2004, 10:5647-5649.
21. Melana S.M., Picconi M.A., Rossi C., Mural J., Alonio L.V., Teyssie A., et al. Detection of murine mammary tumor virus (MMTV) ENV gene-like sequences in breast cancer from Argentine patients. Medicina (B Aires) 2002, 62:323-327.
22. Szabo S., Haislip A.M., Traina-Dorge V., Costin J.M., Crawford B.E., Wilson R.B., et al. Human, rhesus macaque, and feline sequences highly similar to mouse mammary tumor virus sequences. Microsc Res Tech 2005, 68:209-221.
23. Wang Y., Go V., Holland J.F., Melana S.M., Pogo B.G. Expression of mouse mammary tumor virus-like ENV gene sequences in human breast cancer. Clin Cancer Res 1998, 4:2565-2568.
24. Wang Y., Holland J.F., Bleiweiss I.J., Melana S., Liu X., Pelisson I., et al. Detection of mammary tumor virus ENV gene-like sequences in human breast cancer. Cancer Res 1995, 55:5173-5179.
25. Wang Y., Pelisson I., Melana S.M., Go V., Holland J.F., Pogo B.G. MMTV-like ENV gene sequences in human breast cancer. Arch Virol 2001, 146:171-180.
26. Mant C., Cason J. A human murine mammary tumour virus-like agent is an unconvincing aetiological agent for human breast cancer. Rev Med Virol 2004, 14:169-177.
27. Mant C., Cason J. Mouse mammary tumor virus and human breast cancer. Cancer Res 2005, 65. (1112; author reply 1112-3).
28. Mant C., Gillett C., D'Arrigo C., Cason J. Human murine mammary tumour virus-like agents are genetically distinct from endogenous retroviruses and are not detectable in breast cancer cell lines or biopsies. Virology 2004, 318:393-404.
29. Selmi C., Ross S.R., Ansari A.A., Invernizzi P., Podda M., Coppel R.L., et al. Lack of immunological or molecular evidence for a role of mouse mammary tumor retrovirus in primary biliary cirrhosis. Gastroenterology 2004, 127:493-501.
30. Witt A., Hartmann B., Marton E., Zeillinger R., Schreiber M., Kubista E. The mouse mammary tumor virus-like ENV gene sequence is not detectable in breast cancer tissue of Austrian patients. Oncol Rep 2003, 10:1025-1029.
31. Voisset C., Weiss R.A., Griffiths D.J. Human RNA " rumor" viruses: the search for novel human retroviruses in chronic disease. Microbiol Mol Biol Rev 2008, 72:157-196. (table of contents).
32. Bentvelzen P., Daams J. Mammary-tumor virus activity in brain and liver of GR strain mice. Eur J Cancer 1970, 6:273-276.
33. Acha-Orbea H., Finke D., Attinger A., Schmid S., Wehrli N., Vacheron S., et al. Interplays between mouse mammary tumor virus and the cellular and humoral immune response. Immunol Rev 1999, 168:287-303.
34. Buetti E., Diggelmann H. Cloned mouse mammary tumor virus DNA is biologically active in transfected mouse cells and its expression is stimulated by glucocorticoid hormones. Cell 1981, 23:335-345.
35. Varmus H.E., Ringold G., Yamamoto K.R. Regulation of mouse mammary tumor virus gene expression by glucocorticoid hormones. Monogr Endocrinol 1979, 12:253-278.
36. Montano-Loza A.J., Wasilenko S., Bintner J., Mason A.L. Cyclosporin A protects against primary biliary cirrhosis recurrence after liver transplantation. Am J Transplant 2010, 10:852-858.
37. Montano-Loza AJ, Wasilenko S, Bintner J, Mason AL. Cyclosporine A inhibits in vitro replication of beta retrovirus associated with primary biliary cirhosis. Liver Int 2010;30:871-7.
38. McDermid J., Chen M., Li Y., Wasilenko S., Bintner J., McDougall C., et al. Reverse transcriptase activity in patients with primary biliary cirrhosis and other autoimmune liver disorders. Aliment Pharmacol Ther 2007, 26:587-595.
39. Faschinger A., Rouault F., Sollner J., Lukas A., Salmons B., Gunzburg W.H., et al. Mouse mammary tumor virus integration site selection in human and mouse genomes. J Virol 2007, 82:1360-1367.
40. Indik S., Mojiri A., Wong I., Zhang G., Wasilenko S., Mason A. Isolation of a human beta retrovirus resembling mouse mammary tumor virus from patients with primary biliary cirrhosis. Retrovirology 2009, 6:55.
41. Johal H., Scott G.M., Jones R., Camaris C., Riordan S., Rawlinson W.D. Mouse mammary tumour virus-like virus (MMTV-LV) is present within the liver in a wide range of hepatic disorders and unrelated to nuclear p53 expression or hepatocarcinogenesis. J Hepatol 2009, 50:548-554.
42. Mason A., Xu L., Shen Z., Fodera B., Joplin R., Neuberger J., et al. Patients with primary biliary cirrhosis make antiviral and antimitochondrial antibodies to mouse mammary tumor virus. Gastroenterology 2004, 127. (1863-4; author reply 1864-5).
43. Indik S., Gunzburg W.H., Kulich P., Salmons B., Rouault F. Rapid spread of mouse mammary tumor virus in cultured human breast cells. Retrovirology 2007, 4:73.
44. Indik S., Gunzburg W.H., Salmons B., Rouault F. Mouse mammary tumor virus infects human cells. Cancer Res 2005, 65:6651-6659.
45. Irie J., Wu Y., Wicker L.S., Rainbow D., Nalesnik M.A., Hirsch R., et al. NOD.c3c4 congenic mice develop autoimmune biliary disease that serologically and pathogenetically models human primary biliary cirrhosis. J Exp Med 2006, 203:1209-1219.
46. Koarada S., Wu Y., Fertig N., Sass D.A., Nalesnik M., Todd J.A., et al. Genetic control of autoimmunity: protection from diabetes, but spontaneous autoimmune biliary disease in a nonobese diabetic congenic strain. J Immunol 2004, 173:2315-2323.
47. Mason A.L. An autoimmune biliary disease mouse model for primary biliary cirrhosis: something for everyone. Hepatology 2006, 44:1047-1050.
48. Graham D., Chen M., Zhang G., Swain M., Trauner M., Mason A. The NOD.c3c4 mouse model of PBC develops both mouse mammary tumor virus and aberrant mitochondrial antigen expression in bile ducts. Hepatology 2008, 48:598A.
49. Subsin B., Chen C., Girgis S., Mason A. Mouse mammary tumor virus triggers viral cholangitis in the NOD.c3c4 mousemodel of primary biliary cirrhosis. Hepatology 2009, 50:998A.
50. Mason A.L., Farr G.H., Xu L., Hubscher S.G., Neuberger J.M. Pilot studies of single and combination antiretroviral therapy in patients with primary biliary cirrhosis. Am J Gastroenterol 2004, 99:2348-2355.
51. Mason A.L., Wasilenko S.T. Other potential medical therapies: the use of antiviral agents to investigate and treat primary ciliary cirrhosis. Clin Liver Dis 2008, 12. 445-60; xi.
52. Mason A.L., Lindor K.D., Bacon B.R., Vincent C., Neuberger J.M., Wasilenko S.T. Clinical trial: randomized-controlled trial of zidovudine and lamivudine for patients with primary biliary cirrhosis stabilized on ursodiol. Aliment Pharmacol Ther 2008, 28:886-894.
53. Mason A, Luketic V, Lindor K, Hirschfield G, Gordon S, Mayo M, et al. Farnesoid-X receptor agonists: a new class of drugs for the treatment of PBC? An international study evaluating the addition of INT-747 to ursodeoxycholic acid. J Hepatol 2010;52(suppl.1):S1-S2.
54. Shaw T., Locarnini S.A. Hepatic purine and pyrimidine metabolism: implications for antiviral chemotherapy of viral hepatitis. Liver 1995, 15:169-184.
55. Volberding P.A., Lagakos S.W., Koch M.A., Pettinelli C., Myers M.W., Booth D.K., et al. Zidovudine in asymptomatic human immunodeficiency virus infection A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases. N Engl J Med 1990, 322:941-949.
56. Locarnini S., Warner N. Major causes of antiviral drug resistance and implications for treatment of hepatitis B virus monoinfection and coinfection with HIV. Antivir Ther 2007, 12(Suppl. 3):H15-H23.
57. Palella F.J., Delaney K.M., Moorman A.C., Loveless M.O., Fuhrer J., Satten G.A., et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection HIV Outpatient Study Investigators. N Engl J Med 1998, 338:853-860.
58. Schembri G., Schober P. HIV and human beta retrovirus co-infection: a case report. HIV Medicine 2010, 11:135.
59. Poupon R., Poupon R.E. Retrovirus infection as a trigger for primary biliary cirrhosis?. Lancet 2004, 363:260-261.
60. Marshall B.J., Goodwin C.S., Warren J.R., Murray R., Blincow E.D., Blackbourn S.J., et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988, 2:1437-1442.